How Selegiline (( - )-deprenyl) Slows Brain AgingeBook - 2012
This e-book is a reference on Selegiline (( - )-Deprenyl) effects on the brain. Selegiline, described in thousands of research papers, is registered in over 60 countries. At present, more than one hundred preparations containing selegiline circulate in the global market under different brand names. They are widely used in the treatment of Parkinson's disease, Alzheimer's disease, major depression and as a geroprotective / anti-aging drug. (( - )-Deprenyl) selegiline, the first selective inhibitor of B-type MAO which, in contrast to the known MAO inhibitors, did not potentiate the effect of tyra.
Publisher: [Place of publication not identified] : Bentham Science Publishers, 2012
Characteristics: 1 online resource (xvi, 142 pages)